While trunk control is essential for daily activities and motor function, there is currently sparse information regarding the psychometric properties of the outcome measures used for assessing trunk control in Duchenne muscular dystrophy (DMD), characterized by proximal muscle weakness. The Trunk Control Measurement Scale (TCMS) was developed to assess trunk control in children with cerebral palsy. We aimed to examine the reliability and validity of the Turkish version of the TCMS for children with DMD. We determined the functional level of 52 children with DMD (median age: 8.83 years) with the Vignos Scale, and we further evaluated them with the Motor Function Measure (MFM), a gold standard for determining the validity of the TCMS. Internal consistency of the Turkish TCMS was excellent with a Cronbach’s alpha of .95. Intraclass correlation coefficient (ICC) values for intra-rater reliability were between 0.90–0.96 and for inter-rater reliability were between 0.91–0.95. We reported positive moderate to strong correlations between the TCMS and trunk flexors strength (p < .001, r = 0.77), back extensors strength (p < .001, r = 0.68) and MFM (p < .001, r = 0.85). Thus, we found the Turkish version of TCMS to be a reliable and valid instrument for assessing trunk control of children with DMD in clinical and research settings.
Alemdaroglu-GürbüzI.BulutN.BozgeyikS., et al. (2019). Reliability and validity of the Turkish translation of pedsql™ multidimensional Fatigue scale in Duchenne Muscular Dystrophy. Neurosciences journal, 24(4), 302–310.
2.
AyreC.ScallyA. J. (2014). Critical values for lawshe’s content validity ratio: Revisiting the original methods of calculation. Measurement & Evaluation in Counseling & Development, 47(1), 79–86.
3.
BaldaufK. L.SwensonD. K.MedeirosJ. M., et al. (1984). Clinical assessment of trunk flexor muscle strength in healthy girls 3 to 7 years of age. Physical Therapy, 64(8), 1203–1208.
4.
BentlerP. M.BonettD. G. (1980). Significance tests and goodness of fit in the analysis of covariance structures. Psychological Bulletin, 88(3), 588.
5.
BérardC.PayanC.HodgkinsonI., et al. (2005). A motor function measure scale for neuromuscular diseases. Construction and validation study. Neuromuscular Disorders, 15(7), 463–470.
6.
BodilsenA. C.Juul-LarsenH. G.PetersenJ., et al. (2015). Feasibility and inter-rater reliability of physical performance measures in acutely admitted older medical patients. PLoS One, 10(2), e0118248.
7.
BulutN.Alemdaroğlu-GürbüzI.TopaloğluH., et al. (2022). The association between trunk control and upper limb functions of children with Duchenne muscular dystrophy. Physiotherapy: Theory and Practice, 38(1), 46–54.
8.
ButlerP.SaavedraM. S.SofranacM. M., et al. (2010). Refinement, reliability and validity of the segmental assessment of trunk control (SATCo). Pediatric Physical Therapy: The Official Publication of the Section on Pediatrics of the American Physical Therapy Association, 22(3), 246.
9.
DoğanN. Ö. (2018). Bland-altman analysis: A paradigm to understand correlation and agreement. Turkish journal of emergency medicine, 18(4), 139–141.
10.
EmeryA. E. (1991). Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscular Disorders, 1(1), 19–29.
11.
FlorenceJ. M.PandyaS.KingW. M., et al. (1992). Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Physical Therapy, 72(2), 115–122.
12.
GuiraudS.ChenH.BurnsD. T., et al. (2015). Advances in genetic therapeutic strategies for Duchenne muscular dystrophy. Experimental Physiology, 100(12), 1458–1467.
13.
HeyrmanL.DesloovereK.MolenaersG., et al. (2013). Clinical characteristics of impaired trunk control in children with spastic cerebral palsy. Research in Developmental Disabilities, 34(1), 327–334.
14.
HeyrmanL.MolenaersG.DesloovereK., et al. (2011). A clinical tool to measure trunk control in children with cerebral palsy: The trunk control measurement scale. Research in Developmental Disabilities, 32(6), 2624–2635.
15.
HoffmanE. P.BrownJr R. H.KunkelL. M. (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell, 51(6), 919–928.
16.
İnalH. S.TarakciE.TarakciD., et al. (2017). Turkish version of the motor function measure scale (MFM-32) forneuromuscular diseases: A cross-cultural adaptation, reliability, and validity study. Turkish Journal of Medical Sciences, 47(6), 1826–1833.
17.
JeonJ.-Y.ShinW.-S. (2014). Reliability and validity of the Korean version of the Trunk Control Measurement Scale (TCMS-K) for children with cerebral palsy. Research in Developmental Disabilities, 35(3), 581–590.
18.
KooT. K.LiM. Y. (2016). A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of chiropractic medicine, 15(2), 155–163.
19.
MarsicoP.MittereggerE.BalzerJ., et al. (2017). The trunk control measurement scale: Reliability and discriminative validity in children and young people with neuromotor disorders. Developmental Medicine and Child Neurology, 59(7), 706–712.
20.
MartiniJ.VoosM. C.HukudaM. E., et al. (2014). Compensatory movements during functional activities in ambulatory children with Duchenne muscular dystrophy. Arquivos de neuro-psiquiatria, 72, 5–11.
21.
MendellJ. R.ShillingC.LeslieN. D., et al. (2012). Evidence‐based path to newborn screening for Duchenne muscular dystrophy. Annals of Neurology, 71(3), 304–313.
22.
MittereggerE.MarsicoP.BalzerJ., et al. (2015). Translation and construct validity of the Trunk Control Measurement Scale in children and youths with brain lesions. Research in Developmental Disabilities, 45, 343–352.
23.
OzalC.AriG.GunelM. K. (2019). Inter–intra observer reliability and validity of the Turkish version of Trunk Control Measurement Scale in children with cerebral palsy. Acta Orthopaedica et Traumatologica Turcica, 53(5), 381–384.
24.
Parlak DemirY.YıldırımS. A. (2015). Reliability and validity of Trunk Control Test in patients with neuromuscular diseases. Physiotherapy: Theory and Practice, 31(1), 39–44.
25.
PeetersL.KingmaI.Van DieënJ., et al. (2019). Don’t forget the trunk in Duchenne muscular dystrophy patients: More muscle weakness and compensation than expected. Journal of NeuroEngineering and Rehabilitation, 16, 1–10.
26.
PrionS.HaerlingK. A. (2014). Making sense of methods and measurement: Spearman-rho ranked-order correlation coefficient. Clinical Simulation in Nursing, 10(10), 535–536.
27.
SáC. S..CdFagundesI. K.AraújoT. B., et al. (2016). The relevance of trunk evaluation in Duchenne muscular dystrophy: The segmental assessment of trunk control. Arquivos de neuro-psiquiatria, 74, 791–795.
28.
SharmaB. (2016). A focus on reliability in developmental research through Cronbach’s Alpha among medical, dental and paramedical professionals. Asian Pacific Journal of Health Sciences, 3(4), 271–278.
29.
TerweeC. B.MokkinkL. B.KnolD. L., et al. (2012). Rating the methodological quality in systematic reviews of studies on measurement properties: A scoring system for the COSMIN checklist. Quality of Life Research, 21, 651–657.
30.
Van RuitenH.BushbyK.GuglieriM. (2017). State of the art advances in Duchenne muscular dystrophy. Engineering Management Journal, 2(1), 90–99.
31.
VerheydenG.NieuwboerA.MertinJ., et al. (2004). The trunk impairment scale: A new tool to measure motor impairment of the trunk after stroke. Clinical Rehabilitation, 18(3), 326–334.
32.
VignosP. J.SpencerG. E.ArchibaldK. C. (1963). Management of progressive muscular dystrophy of childhood. Jama, 184(2), 89–96.
